Table 1.
Untreated Neurons | S1PR1 siRNA Treated | Scramble | |
---|---|---|---|
Resting membrane potential, mV | |||
Control | −56.5 ± 1.7 | −61.2 ± 1.3 | −59.9 ± 1.4 |
2 min | −52.1 ± 2.2 | −62.6 ± 1.8 | −58.8 ± 1.5 |
4 min | −49.3 ± 4.2* | −63.0 ± 1.8 | −56.9 ± 1.8* |
6 min | −47.8 ± 4.4* | −63.2 ± 1.9 | −55.1 ± 2.2* |
10 min | −48.8 ± 4.5* | −62.5 ± 2.0 | −51.8 ± 2.6* |
Firing threshold, mV | |||
Control | −15.7 ± 1.7 | −16.5 ± 3.5 | −18.6 ± 9.9 |
2 min | −18.2 ± 1.6 | −14.8 ± 4.8 | −19.3 ± 10.7 |
4 min | −17.1 ± 1.8 | −12.8 ± 3.8 | −19.7 ± 10.4 |
6 min | −14.3 ± 2.6 | −14.1 ± 3.4 | −18.4 ± 11.1 |
10 min | −16.1 ± 2.8 | −15.1 ± 3.2 | −22.7 ± 11.3 |
Rheobase, pA | |||
Control | 225 ± 67 | 493 ± 206 | 341 ± 166 |
2 min | 120 ± 23 | 504 ± 210 | 280 ± 124 |
4 min | 123 ± 27 | 525 ± 202 | 268 ± 135 |
6 min | 111 ± 25 | 528 ± 198 | 259 ± 140 |
10 min | 98 ± 18* | 527 ± 226 | 196 ± 114* |
Normalized rheobase | |||
Control | 1.0 ± 0 | 1.0 ± 0 | 1.0 ± 0 |
2 min | 0.63 ± 0.11* | 0.99 ± 0.04 | 0.76 ± 0.10 |
4 min | 0.61 ± 0.14* | 1.17 ± 0.08 | 0.75 ± 0.05 |
6 min | 0.55 ± 0.10* | 1.17 ± 0.05 | 0.72 ± 0.11* |
10 min | 0.53 ± 0.11* | 1.12 ± 0.07 | 0.47 ± 0.13* |
Resistance at threshold, MΩ | |||
Control | 268 ± 78 | 223 ± 55 | 296 ± 82 |
2 min | 336 ± 71 | 227 ± 42 | 335 ± 107 |
4 min | 354 ± 110 | 209 ± 43 | 372 ± 124 |
6 min | 366 ± 75 | 206 ± 47 | 378 ± 105 |
10 min | 379 ± 62 | 226 ± 55 | 406 ± 118 |
Normalized resistance at threshold | |||
Control | 1.0 ± 0 | 1.0 ± 0 | 1.0 ± 0 |
2 min | 1.48 ± 0.26 | 1.09 ± 0.07 | 1.14 ± 0.09 |
4 min | 1.45 ± 0.22 | 1.01 ± 0.06 | 1.24 ± 0.13 |
6 min | 1.62 ± 0.26 | 0.96 ± 0.04 | 1.35 ± 0.17 |
10 min | 1.85 ± 0.51 | 0.99 ± 0.04 | 1.65 ± 0.38 |
Values are means ± SE. Untreated neurons, n = 5; S1PR1 siRNA treated, n = 11; Scramble, n = 7.
P < 0.05, repeated-measures ANOVA.